本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

C4 Therapeutics, Inc.

1.48
-0.0400-2.63%
盘后1.500.0200+1.35%16:51 EDT
成交量:72.82万
成交额:107.90万
市值:1.05亿
市盈率:-1.00
高:1.56
开:1.54
低:1.44
收:1.52
数据加载中...
2024/02/02

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/11

重要事件披露

Form 8-K - Current report
2024/01/10

重要事件披露

Form 8-K - Current report
2024/01/05

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/26

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/22

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/12

重要事件披露

Form 8-K - Current report
2023/12/12

重要事件披露

Form 8-K - Current report
2023/11/20

重要事件披露

Form 8-K - Current report
2023/11/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/01

重要事件披露

Form 8-K - Current report
2023/09/05

重要事件披露

Form 8-K - Current report
2023/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

重要事件披露

Form 8-K - Current report
2023/07/25

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/06/20

重要事件披露

Form 8-K - Current report
2023/06/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/05/30

重要事件披露

Form 8-K - Current report